Novel SARS-CoV-2 Variant in Travelers from Brazil to Japan.

Publisher: National Center for Infectious Diseases, Centers for Disease Control and Prevention (CDC) Country of Publication: United States NLM ID: 9508155 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1080-6059 (Electronic) Linking ISSN: 10806040 NLM ISO Abbreviation: Emerg Infect Dis Subsets: MEDLINE

Original Publication: Atlanta, GA : National Center for Infectious Diseases, Centers for Disease Control and Prevention (CDC), [1995-

Communicable Diseases, Imported*/epidemiology ; Communicable Diseases, Imported*/physiopathology ; Communicable Diseases, Imported*/therapy ; Communicable Diseases, Imported*/virology ; SARS-CoV-2*/genetics ; SARS-CoV-2*/isolation & purification ; COVID-19 Drug Treatment*; Adult ; Basic Reproduction Number ; Brazil/epidemiology ; COVID-19/epidemiology ; COVID-19/therapy ; COVID-19/transmission ; COVID-19/virology ; Hospitalization ; Humans ; Japan/epidemiology ; Male ; Mutation ; Quarantine/methods ; Symptom Assessment/methods ; Travel-Related Illness ; Treatment Outcome

Multiple severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants with higher transmission potential have been emerging globally, including SARS-CoV-2 variants from the United Kingdom and South Africa. We report 4 travelers from Brazil to Japan in January 2021 infected with a novel SARS-CoV-2 variant with an additional set of mutations.

Keywords: Brazil; COVID-19; Japan; SARS; SARS-CoV-2; coronavirus; coronavirus disease; respiratory infections; severe acute respiratory syndrome coronavirus 2; viruses; zoonoses

Date Created: 20210210 Date Completed: 20210401 Latest Revision: 20221207

20240105

PMC8007308

10.3201/eid2704.210138

33567247